Goat Polyclonal Antibody
Catalog No. G33-62G
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
G33-62G-1000 | 1 ml | $255 | |
G33-62G-BULK | BULK | Contact Us |
Overview:
Affinity purified rabbit immunoglobulins were used to raise goat antibodies specific to the rabbit IgG. The goat immune serum is subsequently affinity purified using immunoglobulins immobilized to agarose. The antibodies are then conjugated to horse radish peroxidase (HRP) by reductive amination in a 2:1 molar ratio. The HRP conjugated secondary antibody can recognize the primary immunoglobulin and give a signal in the presence of a chemiluminescent substrate. The signal can be detected using an electronic imager or autoradiography film (1).
References:
1. Nakane PK, Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of antigens, J Histochem Cytochem 1966, 14:929
Specificity:
Anti-Rabbit HRP conjugated secondary antibody recognizes rabbit IgG and IgM.
Cross Reactivity:
IgG and IgM from Rabbit
(Other rabbit immunoglobulins may also be detectable)
Host / Isotype / Clone#:
Goat Polyclonal
Immunogen:
Affinity purified rabbit immunoglobulins
Purification:
Affinity purified with rabbit immunoglobulins on agarose followed by adsorption with human serum albumin and human gamma globulins
Stability:
Store at 4°C for several months, and at -20°C for longer periods; do not add NaN3 as this will inhibit the HRP enzyme. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For optimal performance, avoid repeated handling and multiple freeze/thaw cycles.
Sample Data:
Representative western blot (1:2000) from HeLa cell lysate using a rabbit pAb RSK1 antibody recognized by Anti-Rabbit HRP
M. Wrighta Victoria et al., Differential activities of the Drosophila JAK/STAT pathway ligands Upd, Upd2 and Upd3 Cellular Signalling May 2011 10.1016/j.cellsig.2011.01.020
KC Zhu et al., Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1. Oncology Letters October 2015 10.3892/ol.2015.3619
STAY CONNECTED
Fax: 1-604-232-4601